T D Blydt-Hansen
Overview
Explore the profile of T D Blydt-Hansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiebe C, Gibson I, Blydt-Hansen T, Pochinco D, Birk P, Ho J, et al.
Am J Transplant
. 2015 Jun;
15(11):2921-30.
PMID: 26096305
Understanding rates and determinants of clinical pathologic progression for recipients with de novo donor-specific antibody (dnDSA), especially subclinical dnDSA, may identify surrogate endpoints and inform clinical trial design. A consecutive...
2.
Blydt-Hansen T, Sharma A, Gibson I, Mandal R, Wishart D
Am J Transplant
. 2014 Aug;
14(10):2339-49.
PMID: 25138024
The goal of this study was to evaluate the utility of urinary metabolomics for noninvasive diagnosis of T cell-mediated rejection (TCMR) in pediatric kidney transplant recipients. Urine samples (n = ...
3.
Wiebe C, Pochinco D, Blydt-Hansen T, Ho J, Birk P, Karpinski M, et al.
Am J Transplant
. 2013 Oct;
13(12):3114-22.
PMID: 24164958
De novo donor-specific antibody (dnDSA) develops in 15-25% of renal transplant recipients within 5 years of transplantation and is associated with 40% lower graft survival at 10 years. HLA epitope...
4.
Wiebe C, Gibson I, Blydt-Hansen T, Karpinski M, Ho J, Storsley L, et al.
Am J Transplant
. 2012 Mar;
12(5):1157-67.
PMID: 22429309
The natural history for patients with de novo donor-specific antibodies (dnDSA) and the risk factors for its development have not been well defined. Furthermore, clinical and histologic correlation with serologic...
5.
Blydt-Hansen T, Tenenhouse H, Goodyer P
Pediatr Nephrol
. 1999 Aug;
13(7):607-11.
PMID: 10460513
X-linked hypophosphatemia (XLH), a renal phosphate (Pi) wasting disorder with defective bone mineralization, is caused by mutations in the PHEX gene (a Pi-regulating gene with homology to endopeptidases on the...